Sojournix, Inc. — Form D/A
Sojournix, Inc. of ARLINGTON, MA, a company, filed a Form D amendment with the SEC on 2017-12-21. The offering totals $19.4M, of which $19.0M was reported sold. Industry: Pharmaceuticals.
Offering
- Filed: 2017-12-21
- Form: D/A
- Accession: 0001674444-17-000003
- Industry: Pharmaceuticals
- Exemptions: 06b
- Total offering: $19.4M
- Amount sold: $19.0M
- Remaining: $413K
- Investors: 7
- Date of first sale: 2017-07-27
- Security types: equity, debt
- Revenue range: Decline to Disclose
- SEC file number: 021-292462
Issuer
- Name: Sojournix, Inc.
- CIK: 0001674444
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2016
- Address: 1167 MASSACHUSETTS AVE., ARLINGTON, MA, 02476
- Phone: 781-795-4700
Officers, directors & promoters (13)
| Name | Role | Location |
|---|
| Aaron L Davis | Director | Arlington, MA |
| Martin L Freed | Director | Arlington, MA |
| Peter L Kolchinsky | Director | Arlington, MA |
| Peter L Lanciano | Director | Arlington, MA |
| Scott L Rakestraw | Director | Arlington, MA |
| Scott S Rakestraw | Director | Arlington, MA |
| Daniel S Grau | Director | Arlington, MA |
| Daniel S Grau | Executive Officer | Arlington, MA |
| Martin S Freed | Director | Arlington, MA |
| Aaron S Davis | Director | Arlington, MA |
| Peter S Lanciano | Director | Arlington, MA |
| Scott L Rakestraw | Executive Officer | Arlington, MA |
| Peter S Kolchinsky | Director | Woburn, MA |
Other filings by this issuer (4)
More